Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00531570 · ClinicalTrials.gov registry record
Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma
A clinical trial of Ovarian Neoplasms, sponsored by NYU Langone Health.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT00531570: Completed study of Ovarian Neoplasms, sponsored by NYU Langone Health.
NCT00531570 is a study of Ovarian Neoplasms that has completed, run by NYU Langone Health. The registered enrollment target is 100 participants, below the 365-participant average among 38 other Ovarian Neoplasms trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00531570, a study of Ovarian Neoplasms, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
In the United States, ovarian cancer is the fifth most common cancer to develop in women and causes more deaths than all other gynecologic malignancies combined. Because of the difficulties in detecting early stage ovarian cancer, 75% of women continue to be diagnosed with advanced stage disease (stage III or IV). The National Ovarian Cancer Early Detection Program (NOCEDP) as part of the National Cancer Institute's Early Detection Research Network (EDRN) is committed to the development of effective means for the accurate detection of early stage ovarian cancer. The last decade has seen rapid technological advances in diagnostic ultrasonography with the recent development of three-dimensional imaging. Initial studies suggest that these new technologies improve upon the diagnostic accuracy of two-dimensional transvaginal imaging in the differentiation between benign and malignant pathology. This improved diagnostic accuracy may promote improved patient care by separating complex benign masses from ovarian cancer therefore facilitating appropriate treatment.
Conditions Studied
Study Locations (1)
New York
- NYU Cancer Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2005-02 |
| Est. Completion | 2009-04 |
What the finished NCT00531570 record still lists
NCT00531570 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 365-participant average among 38 other Ovarian Neoplasms trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Ovarian Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT00531570 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00531570 about?
NCT00531570 is a clinical study titled "Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma". In the United States, ovarian cancer is the fifth most common cancer to develop in women and causes more deaths than all other gynecologic malignancies combined. Because of the difficulties in detecting early stage ovarian cancer, 75% of women continue to be diagnosed with advanced stage disease (st...
What is the current status of trial NCT00531570?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2005-02. Estimated completion is 2009-04.
What conditions does trial NCT00531570 study?
This clinical trial studies the following conditions: Ovarian Neoplasms.
Who is sponsoring clinical trial NCT00531570?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00531570 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00531570's enrollment target sits among peer trials
100 26th of 38 higher than 12 of 38 other Ovarian Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ovarian Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RECRUITING · Phase 1
-
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
RECRUITING
-
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RECRUITING · Phase 1
-
Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
RECRUITING · NA
-
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia